Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3048]
News [6163]
Articles [120]
Editorials [18]
Conferences [182]
elearning [32]
Breast cancer recurrence risk lingers years after treatment ends
Breast cancer recurrence risk lingers years after treatment ends
Novel approach could limit common complications of immunotherapy
Novel approach could limit common complications of immunotherapy
How chronic inflammation tips the balance of immune cells to promote liver cancer
How chronic inflammation tips the balance of immune cells to promote liver cancer
Misregulated protein breakdown promotes leukemias and brain cancer
Misregulated protein breakdown promotes leukemias and brain cancer
How cells detect, mend DNA damage may improve chemotherapy
How cells detect, mend DNA damage may improve chemotherapy
Mathematical model to predict immunotherapy success
Mathematical model to predict immunotherapy success
Scientists exploit leaks in blood brain barrier to treat glioblastoma
Scientists exploit leaks in blood brain barrier to treat glioblastoma
FDA approves alectinib as first-line treatment for ALK positive NSCLC
FDA approves alectinib as first-line treatment for ALK positive NSCLC
Circulating tumour cells associated with relapse in late-stage melanoma patients
Circulating tumour cells associated with relapse in late-stage melanoma patients
Personalised Medicine: Hope, Hype and Pitfalls
Personalised Medicine: Hope, Hype and Pitfalls

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation